The goal of the current study is to determine if tau pathology within the PCC and other posterior cortical nodes of the DMN, regions of early neuropathology and neurodegeneration across clinical phenotypes of symptomatic Alzheimer’s disease, impacts functional connectivity within the DMN in a group of atypical Alzheimer’s disease patients. Here, MAPT is linked to early-onset autosomal dominant Alzheimer disease.